Castle Biosciences Inc (CSTL) — Cash Flow Reinvestment Rate
Castle Biosciences Inc (CSTL) has a Cash Flow Reinvestment Rate of 1.15x as of December 2025, reinvesting $30.88 Million (capex $7.18 Million plus investments $23.69 Million) from operating cash flow of $26.93 Million. Check CSTL cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Castle Biosciences Inc Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Castle Biosciences Inc across 4 annual periods. Explore Castle Biosciences Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Castle Biosciences Inc (2019–2025)
Year-by-year capital reinvestment analysis for Castle Biosciences Inc. For live market cap and broader valuation context, see Castle Biosciences Inc (CSTL) total market value.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.59x | $38.04 Million | $64.35 Million | $36.02 Million | ▼ -51.1% |
| 2024 | 1.21x | $78.46 Million | $64.87 Million | $28.33 Million | ▲ +25.6% |
| 2020 | 0.96x | $9.50 Million | $9.87 Million | $4.75 Million | ▲ +260.4% |
| 2019 | 0.27x | $1.87 Million | $7.01 Million | $937.00K | — |